HKSE · 1302.HK
LifeTech Scientific Corporation
HK$1.47-HK$0.08 (-5.16%)
LifeTech Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.24% below the high.
Loading market information…
HKSE · 1789.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
AK Medical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
AK Medical Holdings Limited’s forward annual dividend is HK$0.12 per share, paid annual. The forward yield is 2.59% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
AK Medical Holdings Limited’s next earnings report is currently expected on Mar 31, 2027, with estimated earnings per share of HK$0.22. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow AK Medical Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:05 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2023 | Mar 26, 2024 | HK$0.05-12.72% vs estimate | HK$482.04M+7.66% vs estimate |
|---|
| Q2 2023 | Aug 22, 2023 | HK$0.13+12.53% vs estimate | HK$733.01M+6.42% vs estimate |
|---|
| Q4 2022 | Mar 28, 2023 | HK$0.08+31.45% vs estimate | HK$584.46M-1.7% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.47-HK$0.08 (-5.16%)
LifeTech Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.24% below the high.
HK$18.64-HK$0.58 (-3.02%)
Zylox-Tonbridge Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.43% below the high.
HK$6.22+HK$0.07 (+1.14%)
Medcaptain Medical Technology Co. Ltd. Class H’s quoted price sits in the lower half of its reported 52-week range, 42.94% below the high.
HK$6.70-HK$0.01 (-0.07%)
MicroTech Medical (Hangzhou) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.08% below the high.
HK$51.00-HK$3.25 (-5.99%)
Star Sports Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 82.94% below the high.
HK$0.90+HK$0.03 (+2.87%)
PW Medtech Group Limited’s quoted price sits in the lower half of its reported 52-week range, 41.12% below the high.
HK$4.08+HK$0.18 (+4.62%)
Gaush Meditech Ltd’s quoted price sits in the lower half of its reported 52-week range, 59.16% below the high.
HK$0.71+HK$0.03 (+3.65%)
Vincent Medical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 34.86% below the high.
